MAGEA9 and ovarian carcinoma: Regarding ovarian cancers, expression of MAGE-A4, MAGE-A9, MAGE-A10, and NY-ESO-1 proteins in tumor cells has previously been reported to be associated with poor prognosis [14,40,41,42], but no data regarding sensitivity to chemotherapy treatment have been provided.